Amgen Profit Rises 13%, 2016 Outlook Raised

Amgen Inc. said its second-quarter earnings rose 13% on better-than-expected revenue growth, which was again driven by sales of key drugs such as Enbrel.

from WSJ.com: US Business http://ift.tt/2acsXb8
via IFTTT